European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy.

Saved in:
Bibliographic Details
Title: European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy.
Authors: Scharl S; Department of Radiation Oncology, University Hospital Ulm, Germany. Electronic address: Sophia.scharl@uniklinik-ulm.de., Zamboglou C; Department of Radiation Oncology, Medical Center -Faculty of Medicine, University of Freiburg, Germany., Strouthos I; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus., Farolfi A; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Serani F; Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Koerber SA; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Department of Radiation Oncology, Barmherzige Brüder Hospital Regensburg, Regensburg, Germany., Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany., Peeken JC; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Germany., Vogel MME; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Germany., Kroeze SGC; Radiation Oncology Center KSA-KSB, Canton Hospital of Aarau, Aarau, Switzerland., Guckenberger M; Department of Radiation Oncology, University Hospital Zürich, Switzerland., Krafcsik M; Department of Radiation Oncology, University Hospital Ulm, Germany., Hruby G; Department of Radiation Oncology, Royal North Shore Hospital - University of Sydney, Australia., Emmett L; St Vincent's Clinical School, University of New South Wales, Sydney, Australia., Schmidt-Hegemann NS; Department of Department of Radiotherapy and Oncology, University Hospital, LMU Munich, Germany; German Cancer Consortium (DKTK), Partner Site Munich, 81377 Munich, Germany; Bavarian Cancer Research Center (BZKF), Munich, Germany., Trapp C; Department of Department of Radiotherapy and Oncology, University Hospital, LMU Munich, Germany., Spohn SKB; Department of Radiation Oncology, Medical Center -Faculty of Medicine, University of Freiburg, Germany., Henkenberens C; Department of Radiotherapy and Special Oncology, Medical School Hannover, Hannover, Germany., Mayer B; Institute for Epidemiology and Medical Biometry, University Ulm, Ulm, Germany., Shelan M; Department of Radiation Oncology, Inselspital Bern, Bern University Hospital, University of Bern, Switzerland., Aebersold DM; Department of Radiation Oncology, Inselspital Bern, Bern University Hospital, University of Bern, Switzerland., Thamm R; Department of Radiation Oncology, University Hospital Ulm, Germany., Wiegel T; Department of Radiation Oncology, University Hospital Ulm, Germany.
Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 May; Vol. 194, pp. 110215. Date of Electronic Publication: 2024 Mar 07.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0887
DOI:10.1016/j.radonc.2024.110215